GSK Revenue Growth (YoY) Analysis
Updated 299h ago·SEC filings & market data
Key Takeaway
Revenue growth year-over-year measures how much sales increased compared to the same period last year; GSK's 5.3% means its revenue expanded by that rate.
Sector Performance
33th percentileGSK
5.3%
Sector Median
9.2%
Sector Avg
14.7%
Prior Period
1.5%(Jun 2026)
Deep Analysis
Revenue growth year-over-year measures how much sales increased compared to the same period last year; GSK's 5.3% means its revenue expanded by that rate.
This trails the sector median of 8.7%, placing GSK at the 35th percentile, meaning most peers grow faster. The trend direction is not available, with both the year-over-year change and quarter-over-quarter change marked as N/A, leaving no basis to judge acceleration or deceleration. With a growth level below average and no trend data, the near-term revenue trajectory is uncertain, adding moderate risk rather than a clear opportunity. An investor would need additional data, such as product launches or patent expiries, to assess whether the underperformance will persist. This metric aligns with the overall NEUTRAL verdict, as it neither signals a decisive correction nor a strong recovery. The below-median growth is a mild negative, but without trend information it does not justify a bearish stance.
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about GSK?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
Who are GSK's closest peers by Revenue Growth (YoY)?
The closest peers by Revenue Growth (YoY) include: FCX (-7.3%), INSP (-7.6%), FOX (-8.6%), NVR (-10.5%), HES (-11.2%).
Learn More About Revenue Growth (YoY)
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master GSK's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full GSK research report →GSK
5.3%
Sector Median
9.2%
Sector Avg
14.7%
How GSK's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.